Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | HPGD | P15428 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | F2 | P00734 | 3/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 5/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.47 |
| ▸ | HPN | P05981 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | C1R | P00736 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13701134 | 0.82 | ELANE (0.64) | ELANEALDH1A1KDM4EKMT2AHPGD | |
| SCHEMBL2544499 | 0.82 | ALDH1A1 (0.69) | ELANEALDH1A1KDM4EKMT2AHPGD | |
| SCHEMBL12304281 | 0.81 | VSIR (0.49) | ALDH1A1KDM4EKMT2AHPGDMEN1 | |
| SCHEMBL13701129 | 0.80 | ALDH1A1 (0.68) | ELANEALDH1A1KDM4EKMT2AHPGD | |
| SCHEMBL12758414 | 0.79 | ALDH1A1 (0.49) | ELANEALDH1A1KDM4EKMT2AHPGD | |
| SCHEMBL12352144 | 0.79 | MEN1 (0.56) | ELANEALDH1A1KDM4EKMT2AHPGD | |
| SCHEMBL12758426 | 0.79 | KDM4E (0.49) | ELANEALDH1A1KDM4EKMT2AHPGD | |
| SCHEMBL12352140 | 0.79 | KDM4E (0.71) | ELANEALDH1A1KDM4EKMT2AHPGD | |
| SCHEMBL12352014 | 0.76 | ELANE (0.66) | ELANEALDH1A1NPC1RAB9AC1R | |
| SCHEMBL12758430 | 0.75 | APEX1 (0.61) | ELANEALDH1A1KDM4EKMT2AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8541488-B2 | Formed resin article and polymer film | FUJIFILM CORPORATION (JP) | 2013-09-24 | — | — | US | disclosed |
| US-8541488-B2 | Formed resin article and polymer film | FUJIFILM CORPORATION (JP) | 2013-09-24 | — | — | US | disclosed |
| US-20110186791-A1 | ULTRAVIOLET ABSORBENT COMPOSITION | FUJIFILM CORPORATION (JP) | 2011-08-04 | — | — | US | disclosed |
| US-20110186791-A1 | ULTRAVIOLET ABSORBENT COMPOSITION | FUJIFILM CORPORATION (JP) | 2011-08-04 | — | — | US | disclosed |
| US-20110163284-A1 | LIGHTING UNIT COVER | FUJIFILM CORPORATION (JP) | 2011-07-07 | — | — | US | disclosed |
| US-20110163284-A1 | LIGHTING UNIT COVER | FUJIFILM CORPORATION (JP) | 2011-07-07 | — | — | US | disclosed |
| US-20110092619-A1 | FORMED RESIN ARTICLE AND POLYMER FILM | FUJIFILM CORPORATION (JP) | 2011-04-21 | — | — | US | disclosed |
| US-20110092619-A1 | FORMED RESIN ARTICLE AND POLYMER FILM | FUJIFILM CORPORATION (JP) | 2011-04-21 | — | — | US | disclosed |
| US-7897761-B2 | Heterocyclic compound | FUJIFILM CORPORATION (JP) | 2011-03-01 | — | — | US | disclosed |
| US-7897761-B2 | Heterocyclic compound | FUJIFILM CORPORATION (JP) | 2011-03-01 | — | — | US | disclosed |
| US-20110024701-A1 | Ultraviolet Absorbent Composition | FUJIFILM CORPORATION (JP) | 2011-02-03 | — | — | US | disclosed |
| US-20110024701-A1 | Ultraviolet Absorbent Composition | FUJIFILM CORPORATION (JP) | 2011-02-03 | — | — | US | disclosed |
| US-20100004439-A1 | Heterocyclic Compound | FUJIFLM CORPORATION (JP) | 2010-01-07 | — | — | US | disclosed |
| US-20100004439-A1 | Heterocyclic Compound | FUJIFLM CORPORATION (JP) | 2010-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100004439-A1 | Heterocyclic Compound | PTGER1, CYP1A1, ALOX12 | ELANE 1343/4885ALDH1A1 1205/4885KDM4E 2305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.